You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京醫藥(600713.SH):南藥湖北工業園項目總投資額擬調整為3419萬元
格隆匯 12-16 15:43

格隆匯 12 月 16日丨南京醫藥(600713.SH)公佈,2019年9月,公司同意控股子公司南京醫藥湖北有限公司(“南藥湖北”)立項南藥湖北工業園項目,立項投資額為2690萬元。

現根據南藥湖北發展戰略及湖北市場經營業務需要,南藥湖北現擬建設24米自動化高位立體庫以及相關配套設施,因此南藥湖北工業園項目總投資額擬調整為3419萬元,比原立項投資額2690萬元增加729萬元。

經測算,南藥湖北工業園項目建成後預計支撐約80億元銷售規模,有利於提高土地的利用率和資金投資效率,提升南藥湖北倉儲配送能力和運營管理水平,實現南藥湖北健康快速發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account